Literature DB >> 3806371

Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.

F D Boudinot, W J Jusko.   

Abstract

The pharmacokinetics of prednisolone after 5- and 50-mg/kg doses given as the sodium succinate salt was examined in normal and adrenalectomized rats. Prednisolone, prednisone, and corticosterone concentrations in plasma were determined by HPLC and free prednisolone measured by equilibrium dialysis. Prednisolone sodium succinate was rapidly and completely hydrolyzed to prednisolone as indicated by the absence of the ester from plasma within 5 min after intravenous injection. Prednisolone was rapidly metabolized to prednisone, while corticosterone concentrations in normal rats declined rapidly and were undetectable by 1 hr. Adrenalectomy had no effect on the disposition and protein binding of prednisolone. Dose, however, had a marked effect on prednisolone pharmacokinetics, with mean plasma clearance decreasing from 6.18 to 3.07 L/h per kg and mean steady-state volume of distribution decreasing from 2.14 to 1.05 L/kg from the lower to higher steroid dose. Half-life (0.50 hr) and mean residence time (0.35 hr) were unaffected by dose. Prednisolone plasma protein binding was nonlinear due to saturation of transcortin binding. Changes in pharmacokinetic parameters were not related to the nonlinear plasma binding, but were more likely caused by saturation of elimination pathways and tissue binding sites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3806371     DOI: 10.1007/bf01059655

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  46 in total

1.  Effect of adrenalectomy and cortisone administration on components of the liver microsomal mixed function oxygenase system of male rats which catalyzes ethylmorphine metabolism.

Authors:  J A Castro; F E Greene; P Gigon; H Sasame; J R Gillette
Journal:  Biochem Pharmacol       Date:  1970-08       Impact factor: 5.858

2.  Steroid-protein interactions. 18. Isolation and observations on the polymeric nature of the corticosteroid-binding globulin of the rat.

Authors:  G J Chader; U Westphal
Journal:  Biochemistry       Date:  1968-12       Impact factor: 3.162

3.  Influence of transcortin on degradation and tissue uptake of corticosterone in the infant rat.

Authors:  B Koch; B Lutz; G Schmitt; C Mialhe
Journal:  Horm Metab Res       Date:  1970-09       Impact factor: 2.936

4.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography.

Authors:  J Q Rose; W J Jusko
Journal:  J Chromatogr       Date:  1979-03-01

5.  Analysis of rat serum transcortin-steroid hormone association by column chromatography.

Authors:  M K Agarwal
Journal:  Arch Biochem Biophys       Date:  1977-04-15       Impact factor: 4.013

6.  Determination and prediction of tissue binding of prednisolone in the rabbit.

Authors:  N Khalafallah; W J Jusko
Journal:  J Pharm Sci       Date:  1984-03       Impact factor: 3.534

7.  Binding of prednisolone to alpha 1-acid glycoprotein.

Authors:  R L Milsap; W J Jusko
Journal:  J Steroid Biochem       Date:  1983-02       Impact factor: 4.292

Review 8.  Pharmacokinetic and pharmacodynamic modeling in vivo.

Authors:  N H Holford; L B Sheiner
Journal:  Crit Rev Bioeng       Date:  1981

9.  Serum protein binding of prednisolone in four species.

Authors:  M L Rocci; N F Johnson; W J Jusko
Journal:  J Pharm Sci       Date:  1980-08       Impact factor: 3.534

10.  Dose-dependent protein binding and disposition of prednisolone in rabbits.

Authors:  M L Rocci; W J Jusko
Journal:  J Pharm Sci       Date:  1981-11       Impact factor: 3.534

View more
  12 in total

1.  Iontophoresis-facilitated delivery of prednisolone through throat skin to the trachea after topical application of its succinate salt.

Authors:  Hiroshi Ishii; Tsukasa Suzuki; Hiroaki Todo; Mitsuhiro Kamimura; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2010-12-23       Impact factor: 4.200

2.  Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat.

Authors:  G M Meno-Tetang; Y Y Hon; S Van Wart; W J Jusko
Journal:  Drug Metabol Drug Interact       Date:  1999

3.  Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats.

Authors:  M L Huang; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-10

4.  Physiologically Based Pharmacokinetic Modeling Involving Nonlinear Plasma and Tissue Binding: Application to Prednisolone and Prednisone in Rats.

Authors:  Xiaonan Li; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2020-09-03       Impact factor: 4.030

5.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

6.  Assessment of the impact of dosing time on the pharmacokinetics/pharmacodynamics of prednisolone.

Authors:  Jian Xu; Julia Winkler; Sreedharan Nair Sabarinath; Hartmut Derendorf
Journal:  AAPS J       Date:  2008-06-25       Impact factor: 4.009

7.  Influence of gender on prednisolone effects on whole blood T-cell deactivation and trafficking in rats.

Authors:  G M Meno-Tetang; J V Gobburu; W J Jusko
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

8.  Inhibition of rat splenocyte proliferation with methylprednisolone: in vivo effect of liposomal formulation.

Authors:  E V Mishina; W J Jusko
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

9.  Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.

Authors:  A I Nichols; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

10.  Receptor-mediated pharmacodynamics of prednisolone in the rat.

Authors:  F D Boudinot; R D'Ambrosio; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1986-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.